Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Pharma
FTC targets Novo's Ozempic among 300-plus 'junk' patents
Similar to its first round of challenge against allegedly improper listings in the FDA's Orange Book, the FTC is again targeting drug-device combos.
Angus Liu
May 1, 2024 7:30am
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
Eisai, Biogen's subQ Leqembi delayed amid FDA's data request
Apr 1, 2024 10:45am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
Formosa snags FDA nod for reformulation of decades-old steroid
Mar 5, 2024 11:36am
Grifols preps blood clot treatment approval push after ph. 3 win
Feb 14, 2024 9:10am